GlassScriptPhysician profile
Dalvert H Polanco
NPI 1023637493
$2,471.28
in general payments reported to CMS, 2019-2025
17 companies · $1,069 in 2025
The $1,069 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $301 · 2021: $17.58 · 2022: $320 · 2023: $209 · 2024: $555 · 2025: $1,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.67 |
| Education | $276.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $395.26 | 2025 | Ensite, Cardiomems |
| Edwards Lifesciences Corporation | $388.16 | 2020-2025 | |
| Amgen INC. | $336.57 | 2024-2025 | Repatha, Tepezza, Evenity |
| Mylan Specialty L.P. | $290.67 | 2022-2024 | Yupelri, Yupelri |
| Boston Scientific Corporation | $250.33 | 2022-2025 | Farapulse |
| Bridgebio Pharma, INC. | $146.62 | 2025 | Attruby |
| Angiodynamics, INC. | $137.87 | 2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Janssen Pharmaceuticals, INC | $124.98 | 2022 | |
| Abbvie INC. | $123.71 | 2022-2024 | |
| Genzyme Corporation | $100.00 | 2024 | |
| Horizon Therapeutics Plc | $41.26 | 2023 | Krystexxa |
| Abiomed | $31.89 | 2025 | |
| Pbg Puerto Rico LLC | $31.46 | 2023-2024 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $20.37 | 2025 | Mounjaro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.84 | 2025 | Lifevest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.58 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.71 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalvert Polanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.